| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes, Regulatory | 87 | 2024 | 3108 | 10.080 |
Why?
|
| Forkhead Transcription Factors | 43 | 2024 | 1625 | 6.160 |
Why?
|
| Thymus Gland | 66 | 2024 | 1267 | 3.880 |
Why?
|
| CD4-Positive T-Lymphocytes | 60 | 2024 | 4419 | 2.600 |
Why?
|
| Transcription Factors | 57 | 2024 | 12174 | 2.540 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 8 | 2024 | 152 | 2.460 |
Why?
|
| Diabetes Mellitus, Type 1 | 49 | 2021 | 3440 | 2.410 |
Why?
|
| Gene Expression Regulation | 57 | 2023 | 11930 | 2.230 |
Why?
|
| Mice, Inbred NOD | 65 | 2023 | 1839 | 2.120 |
Why?
|
| Receptors, Antigen, T-Cell | 52 | 2023 | 2568 | 1.930 |
Why?
|
| T-Lymphocytes | 88 | 2024 | 10273 | 1.850 |
Why?
|
| Mice | 309 | 2024 | 82045 | 1.800 |
Why?
|
| Autoimmunity | 35 | 2019 | 1361 | 1.800 |
Why?
|
| T-Lymphocyte Subsets | 21 | 2021 | 1814 | 1.780 |
Why?
|
| Autoimmune Diseases | 31 | 2021 | 2260 | 1.640 |
Why?
|
| Epithelial Cells | 19 | 2024 | 3697 | 1.540 |
Why?
|
| Animals | 352 | 2024 | 169418 | 1.470 |
Why?
|
| Islets of Langerhans | 28 | 2017 | 1349 | 1.460 |
Why?
|
| Self Tolerance | 10 | 2015 | 123 | 1.460 |
Why?
|
| Histocompatibility Antigens Class II | 69 | 2017 | 1438 | 1.440 |
Why?
|
| Arthritis, Experimental | 13 | 2016 | 293 | 1.390 |
Why?
|
| Immune Tolerance | 25 | 2024 | 2326 | 1.340 |
Why?
|
| Transcription, Genetic | 35 | 2024 | 7599 | 1.290 |
Why?
|
| Mice, Transgenic | 97 | 2022 | 9558 | 1.280 |
Why?
|
| Cell Differentiation | 63 | 2024 | 11674 | 1.250 |
Why?
|
| Mice, Inbred C57BL | 98 | 2024 | 22365 | 1.200 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 23 | 2022 | 808 | 1.170 |
Why?
|
| Single-Cell Analysis | 14 | 2024 | 2531 | 1.160 |
Why?
|
| B-Lymphocytes | 33 | 2024 | 4781 | 1.140 |
Why?
|
| Gene Expression Profiling | 42 | 2024 | 9507 | 1.110 |
Why?
|
| Colon | 6 | 2023 | 1804 | 1.060 |
Why?
|
| Lymphocyte Activation | 29 | 2022 | 5495 | 1.040 |
Why?
|
| Intestines | 7 | 2024 | 1912 | 1.020 |
Why?
|
| Intra-Abdominal Fat | 10 | 2024 | 623 | 0.950 |
Why?
|
| Diabetes Mellitus, Experimental | 7 | 2016 | 1121 | 0.930 |
Why?
|
| Polyendocrinopathies, Autoimmune | 6 | 2016 | 56 | 0.870 |
Why?
|
| CD8-Positive T-Lymphocytes | 27 | 2023 | 4642 | 0.860 |
Why?
|
| Arthritis | 11 | 2012 | 685 | 0.820 |
Why?
|
| Immunologic Memory | 12 | 2019 | 1375 | 0.780 |
Why?
|
| Digestive System | 2 | 2020 | 244 | 0.760 |
Why?
|
| Autoantigens | 14 | 2010 | 894 | 0.750 |
Why?
|
| Gene Regulatory Networks | 7 | 2023 | 1755 | 0.740 |
Why?
|
| Dermatitis | 1 | 2023 | 203 | 0.740 |
Why?
|
| Genes, MHC Class II | 29 | 2004 | 433 | 0.720 |
Why?
|
| Inflammation | 28 | 2024 | 10865 | 0.710 |
Why?
|
| Mice, Knockout | 44 | 2024 | 14480 | 0.700 |
Why?
|
| Genetic Diseases, X-Linked | 2 | 2021 | 386 | 0.700 |
Why?
|
| Th17 Cells | 6 | 2024 | 798 | 0.680 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2024 | 863 | 0.680 |
Why?
|
| Metagenome | 4 | 2012 | 465 | 0.680 |
Why?
|
| Quantitative Trait Loci | 8 | 2015 | 2127 | 0.660 |
Why?
|
| Inflammasomes | 1 | 2024 | 541 | 0.660 |
Why?
|
| MAP Kinase Signaling System | 3 | 2015 | 1489 | 0.660 |
Why?
|
| Models, Immunological | 10 | 2015 | 518 | 0.660 |
Why?
|
| Arthritis, Rheumatoid | 15 | 2011 | 3763 | 0.640 |
Why?
|
| Pancreas | 14 | 2017 | 1703 | 0.640 |
Why?
|
| Immunogenetic Phenomena | 2 | 2016 | 23 | 0.640 |
Why?
|
| Gastrointestinal Tract | 3 | 2022 | 840 | 0.640 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 14 | 2013 | 3794 | 0.620 |
Why?
|
| Immune System Diseases | 1 | 2021 | 255 | 0.620 |
Why?
|
| Cytokines | 17 | 2023 | 7449 | 0.610 |
Why?
|
| Allergy and Immunology | 3 | 2012 | 175 | 0.610 |
Why?
|
| Enteric Nervous System | 1 | 2021 | 213 | 0.590 |
Why?
|
| Cell Lineage | 18 | 2014 | 2575 | 0.580 |
Why?
|
| Insulin-Secreting Cells | 7 | 2017 | 900 | 0.580 |
Why?
|
| Organ Culture Techniques | 5 | 2017 | 796 | 0.570 |
Why?
|
| Clostridium | 1 | 2017 | 101 | 0.550 |
Why?
|
| Promoter Regions, Genetic | 18 | 2024 | 5803 | 0.540 |
Why?
|
| Disease Models, Animal | 36 | 2021 | 18388 | 0.540 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2024 | 229 | 0.520 |
Why?
|
| Janus Kinases | 2 | 2016 | 253 | 0.520 |
Why?
|
| Mass Spectrometry | 3 | 2014 | 2204 | 0.520 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 4 | 2022 | 354 | 0.520 |
Why?
|
| Homeostasis | 12 | 2024 | 3351 | 0.510 |
Why?
|
| Interleukin-6 | 4 | 2021 | 3234 | 0.500 |
Why?
|
| Monocytes | 5 | 2022 | 2591 | 0.500 |
Why?
|
| Skin Diseases | 2 | 2023 | 1099 | 0.490 |
Why?
|
| Genetic Variation | 13 | 2024 | 6610 | 0.480 |
Why?
|
| Transcriptional Activation | 3 | 2017 | 1751 | 0.470 |
Why?
|
| Psoriasis | 1 | 2023 | 947 | 0.470 |
Why?
|
| Killer Cells, Natural | 8 | 2016 | 2209 | 0.470 |
Why?
|
| Receptors, Interleukin-2 | 4 | 2006 | 564 | 0.460 |
Why?
|
| Diarrhea | 1 | 2021 | 1320 | 0.460 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2014 | 69 | 0.450 |
Why?
|
| Receptors, Cell Surface | 1 | 2023 | 2819 | 0.440 |
Why?
|
| Antibodies | 8 | 2010 | 2425 | 0.430 |
Why?
|
| Flow Cytometry | 24 | 2021 | 5904 | 0.430 |
Why?
|
| Lymphocyte Subsets | 3 | 2011 | 313 | 0.430 |
Why?
|
| Gene Expression | 15 | 2016 | 7605 | 0.420 |
Why?
|
| Immune System | 6 | 2023 | 801 | 0.420 |
Why?
|
| Sequence Analysis, RNA | 2 | 2020 | 2039 | 0.420 |
Why?
|
| Immunity, Mucosal | 2 | 2016 | 494 | 0.420 |
Why?
|
| Immunogenetics | 1 | 2012 | 62 | 0.410 |
Why?
|
| Glucose-6-Phosphate Isomerase | 6 | 2010 | 49 | 0.410 |
Why?
|
| Intestinal Mucosa | 4 | 2024 | 3048 | 0.410 |
Why?
|
| Immunologic Deficiency Syndromes | 4 | 2014 | 549 | 0.400 |
Why?
|
| Species Specificity | 6 | 2024 | 2422 | 0.400 |
Why?
|
| Antigens, CD | 16 | 2015 | 4029 | 0.400 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 617 | 0.390 |
Why?
|
| RNA Interference | 2 | 2014 | 2832 | 0.390 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2012 | 66 | 0.390 |
Why?
|
| Symbiosis | 6 | 2017 | 297 | 0.380 |
Why?
|
| Organ Specificity | 9 | 2016 | 1972 | 0.380 |
Why?
|
| Regeneration | 7 | 2022 | 1527 | 0.380 |
Why?
|
| Macrophages | 13 | 2024 | 5797 | 0.380 |
Why?
|
| Interleukin-15 | 2 | 2010 | 185 | 0.370 |
Why?
|
| Chromatin | 10 | 2024 | 2969 | 0.370 |
Why?
|
| RNA, Messenger | 19 | 2018 | 12813 | 0.370 |
Why?
|
| Calcium Signaling | 1 | 2015 | 737 | 0.370 |
Why?
|
| Mice, Inbred Strains | 13 | 2016 | 1770 | 0.360 |
Why?
|
| Antigen-Antibody Complex | 3 | 2009 | 511 | 0.360 |
Why?
|
| Peptides | 15 | 2015 | 4368 | 0.350 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2010 | 58 | 0.350 |
Why?
|
| DNA-Binding Proteins | 21 | 2020 | 9623 | 0.350 |
Why?
|
| Antigens, Differentiation | 5 | 2006 | 920 | 0.340 |
Why?
|
| Autoantibodies | 14 | 2012 | 2131 | 0.340 |
Why?
|
| Alleles | 15 | 2023 | 6890 | 0.340 |
Why?
|
| Major Histocompatibility Complex | 19 | 2000 | 877 | 0.340 |
Why?
|
| Interleukin-4 | 5 | 2008 | 1158 | 0.330 |
Why?
|
| DNA-Directed RNA Polymerases | 2 | 2011 | 367 | 0.330 |
Why?
|
| Bone Marrow Cells | 5 | 2017 | 2415 | 0.330 |
Why?
|
| Coculture Techniques | 3 | 2024 | 1343 | 0.330 |
Why?
|
| Adipose Tissue | 8 | 2024 | 3335 | 0.330 |
Why?
|
| Transforming Growth Factor beta | 4 | 2013 | 2003 | 0.320 |
Why?
|
| Epitopes, T-Lymphocyte | 6 | 2007 | 828 | 0.320 |
Why?
|
| Databases, Genetic | 2 | 2020 | 1750 | 0.320 |
Why?
|
| Antigen Presentation | 12 | 2017 | 1251 | 0.310 |
Why?
|
| Mice, Inbred BALB C | 18 | 2020 | 6241 | 0.310 |
Why?
|
| Biodiversity | 1 | 2011 | 346 | 0.310 |
Why?
|
| Molecular Sequence Data | 52 | 2015 | 17647 | 0.310 |
Why?
|
| Mast Cells | 6 | 2012 | 1407 | 0.310 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 7 | 2013 | 897 | 0.310 |
Why?
|
| Clonal Deletion | 8 | 2012 | 75 | 0.310 |
Why?
|
| Nociceptors | 2 | 2024 | 460 | 0.310 |
Why?
|
| Signal Transduction | 17 | 2024 | 23638 | 0.300 |
Why?
|
| Bacteria | 6 | 2021 | 2226 | 0.300 |
Why?
|
| DNA | 25 | 2023 | 7213 | 0.300 |
Why?
|
| Cyclophosphamide | 4 | 2021 | 2224 | 0.290 |
Why?
|
| Muscle, Skeletal | 6 | 2020 | 4984 | 0.290 |
Why?
|
| Immunoglobulin A | 2 | 2022 | 990 | 0.290 |
Why?
|
| Transcription Factor RelA | 2 | 2019 | 254 | 0.290 |
Why?
|
| Mutation | 33 | 2023 | 30243 | 0.290 |
Why?
|
| Humans | 122 | 2024 | 768451 | 0.290 |
Why?
|
| Lymph Nodes | 13 | 2023 | 3472 | 0.280 |
Why?
|
| Spleen | 15 | 2021 | 2298 | 0.280 |
Why?
|
| Myeloid Cells | 2 | 2022 | 833 | 0.280 |
Why?
|
| Cells, Cultured | 21 | 2024 | 19041 | 0.280 |
Why?
|
| Interferon Type I | 2 | 2024 | 566 | 0.270 |
Why?
|
| Interferon-gamma | 13 | 2023 | 3169 | 0.270 |
Why?
|
| Histocompatibility Antigens Class I | 13 | 2022 | 1362 | 0.270 |
Why?
|
| Immunity | 3 | 2014 | 1002 | 0.270 |
Why?
|
| Protein Binding | 13 | 2019 | 9376 | 0.260 |
Why?
|
| Interleukin-17 | 4 | 2022 | 923 | 0.260 |
Why?
|
| Antigens | 6 | 2023 | 1443 | 0.260 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 9 | 2020 | 792 | 0.260 |
Why?
|
| Chromosome Mapping | 11 | 2017 | 4622 | 0.250 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 3 | 2021 | 307 | 0.250 |
Why?
|
| Tretinoin | 1 | 2008 | 525 | 0.250 |
Why?
|
| Genomics | 5 | 2012 | 5909 | 0.250 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2024 | 22 | 0.240 |
Why?
|
| Microarray Analysis | 4 | 2012 | 752 | 0.240 |
Why?
|
| Endocrine System | 1 | 2005 | 113 | 0.240 |
Why?
|
| Adipocytes | 2 | 2024 | 1199 | 0.240 |
Why?
|
| Amino Acid Sequence | 37 | 2015 | 13452 | 0.240 |
Why?
|
| GATA6 Transcription Factor | 1 | 2024 | 55 | 0.240 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 6 | 2022 | 977 | 0.240 |
Why?
|
| Phenotype | 21 | 2021 | 16712 | 0.240 |
Why?
|
| DNA, Z-Form | 1 | 2024 | 3 | 0.230 |
Why?
|
| Venoms | 3 | 2015 | 94 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2015 | 2465 | 0.230 |
Why?
|
| Up-Regulation | 6 | 2010 | 4138 | 0.230 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1104 | 0.230 |
Why?
|
| Neuroimmunomodulation | 2 | 2024 | 188 | 0.230 |
Why?
|
| Joints | 6 | 2010 | 324 | 0.230 |
Why?
|
| Dendritic Cells | 7 | 2021 | 2757 | 0.230 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2024 | 329 | 0.230 |
Why?
|
| Interferon Regulatory Factors | 3 | 2021 | 268 | 0.220 |
Why?
|
| Macrophages, Peritoneal | 1 | 2024 | 244 | 0.220 |
Why?
|
| Male | 65 | 2024 | 364781 | 0.220 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2024 | 165 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2014 | 18048 | 0.210 |
Why?
|
| Immunity, Innate | 11 | 2017 | 3080 | 0.210 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2023 | 127 | 0.210 |
Why?
|
| PPAR gamma | 3 | 2018 | 487 | 0.210 |
Why?
|
| Base Sequence | 49 | 2023 | 12428 | 0.210 |
Why?
|
| Microsatellite Repeats | 3 | 2023 | 784 | 0.210 |
Why?
|
| TRPV Cation Channels | 1 | 2024 | 244 | 0.210 |
Why?
|
| Ligands | 6 | 2024 | 3281 | 0.200 |
Why?
|
| Complement System Proteins | 2 | 2022 | 739 | 0.200 |
Why?
|
| Capillaries | 1 | 2006 | 756 | 0.200 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2023 | 1671 | 0.200 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 8 | 2000 | 317 | 0.200 |
Why?
|
| Interleukin-2 | 5 | 2021 | 1894 | 0.200 |
Why?
|
| Capillary Permeability | 1 | 2006 | 773 | 0.200 |
Why?
|
| Interleukin-7 | 3 | 2013 | 144 | 0.200 |
Why?
|
| Genetic Vectors | 12 | 2006 | 3417 | 0.200 |
Why?
|
| Cell Proliferation | 11 | 2021 | 10494 | 0.200 |
Why?
|
| Complement C3 | 1 | 2024 | 434 | 0.200 |
Why?
|
| Receptors, Immunologic | 3 | 2014 | 1415 | 0.200 |
Why?
|
| Neutrophils | 8 | 2024 | 3790 | 0.200 |
Why?
|
| Ganglia, Spinal | 1 | 2024 | 530 | 0.190 |
Why?
|
| Insulin | 7 | 2017 | 6606 | 0.190 |
Why?
|
| Neurons | 1 | 2021 | 9504 | 0.190 |
Why?
|
| Heligmosomatoidea | 1 | 2021 | 2 | 0.190 |
Why?
|
| H-2 Antigens | 9 | 1997 | 359 | 0.190 |
Why?
|
| Phagocytes | 1 | 2023 | 294 | 0.180 |
Why?
|
| Mice, Inbred CBA | 4 | 2020 | 438 | 0.180 |
Why?
|
| DNA Methylation | 1 | 2015 | 4421 | 0.180 |
Why?
|
| Influenza A virus | 4 | 2022 | 460 | 0.180 |
Why?
|
| Crosses, Genetic | 5 | 2011 | 753 | 0.180 |
Why?
|
| Protein Kinases | 1 | 2008 | 1608 | 0.180 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2021 | 64 | 0.180 |
Why?
|
| Receptors, IgG | 4 | 2012 | 564 | 0.180 |
Why?
|
| DNA Nucleotidylexotransferase | 8 | 1996 | 64 | 0.180 |
Why?
|
| Plasma Cells | 2 | 2017 | 598 | 0.170 |
Why?
|
| Muscle Development | 1 | 2022 | 259 | 0.170 |
Why?
|
| Insulin Resistance | 4 | 2024 | 3974 | 0.170 |
Why?
|
| Genome | 4 | 2021 | 1749 | 0.170 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2022 | 357 | 0.170 |
Why?
|
| Interleukin-18 | 1 | 2021 | 251 | 0.170 |
Why?
|
| PPAR alpha | 1 | 2021 | 177 | 0.170 |
Why?
|
| Cluster Analysis | 5 | 2014 | 2731 | 0.170 |
Why?
|
| Proteomics | 3 | 2010 | 3901 | 0.160 |
Why?
|
| Immunosuppressive Agents | 5 | 2021 | 4213 | 0.160 |
Why?
|
| Enhancer Elements, Genetic | 7 | 2019 | 1368 | 0.160 |
Why?
|
| Ebolavirus | 1 | 2022 | 250 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 3 | 2015 | 1608 | 0.160 |
Why?
|
| Binding Sites | 12 | 2019 | 6030 | 0.160 |
Why?
|
| Disease Progression | 9 | 2017 | 13655 | 0.160 |
Why?
|
| Retroviridae | 3 | 2006 | 850 | 0.160 |
Why?
|
| Mice, Mutant Strains | 18 | 2014 | 1755 | 0.160 |
Why?
|
| Stromal Cells | 6 | 2024 | 1335 | 0.160 |
Why?
|
| Clonal Anergy | 1 | 2019 | 169 | 0.150 |
Why?
|
| Interleukin-1 | 1 | 2002 | 1251 | 0.150 |
Why?
|
| Lysine | 3 | 2015 | 989 | 0.150 |
Why?
|
| Th2 Cells | 5 | 2012 | 1079 | 0.150 |
Why?
|
| Antigen-Presenting Cells | 16 | 2000 | 965 | 0.150 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2012 | 452 | 0.150 |
Why?
|
| NIH 3T3 Cells | 2 | 2017 | 669 | 0.150 |
Why?
|
| Human Body | 1 | 2017 | 38 | 0.150 |
Why?
|
| Female | 52 | 2024 | 396943 | 0.150 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2019 | 182 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2016 | 474 | 0.140 |
Why?
|
| Bile Acids and Salts | 1 | 2019 | 398 | 0.140 |
Why?
|
| Viral Proteins | 2 | 2022 | 1803 | 0.140 |
Why?
|
| Lymphoid Tissue | 5 | 2013 | 446 | 0.140 |
Why?
|
| Interferon-alpha | 1 | 2021 | 909 | 0.140 |
Why?
|
| Obesity | 10 | 2024 | 13065 | 0.140 |
Why?
|
| Neurotransmitter Agents | 1 | 2021 | 666 | 0.140 |
Why?
|
| HEK293 Cells | 8 | 2021 | 4294 | 0.140 |
Why?
|
| Circadian Rhythm | 2 | 2022 | 2585 | 0.140 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2017 | 108 | 0.140 |
Why?
|
| Polymorphism, Genetic | 10 | 2012 | 4249 | 0.140 |
Why?
|
| Immunoblotting | 2 | 2017 | 1650 | 0.130 |
Why?
|
| Lectins, C-Type | 3 | 2013 | 589 | 0.130 |
Why?
|
| Eukaryotic Cells | 1 | 2017 | 192 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2016 | 478 | 0.130 |
Why?
|
| Atlases as Topic | 1 | 2017 | 248 | 0.130 |
Why?
|
| Immunophenotyping | 6 | 2019 | 1869 | 0.130 |
Why?
|
| Interferon-beta | 2 | 2015 | 348 | 0.130 |
Why?
|
| Cell Separation | 4 | 2015 | 1726 | 0.130 |
Why?
|
| Gene Transfer Techniques | 6 | 2000 | 1209 | 0.130 |
Why?
|
| Immunity, Cellular | 3 | 2014 | 1561 | 0.130 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2018 | 633 | 0.130 |
Why?
|
| Histocompatibility Antigens | 5 | 2013 | 478 | 0.130 |
Why?
|
| Immunomodulation | 1 | 2019 | 550 | 0.130 |
Why?
|
| Receptors, CXCR3 | 1 | 2016 | 240 | 0.130 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2015 | 42 | 0.130 |
Why?
|
| Histone Acetyltransferases | 1 | 2017 | 335 | 0.120 |
Why?
|
| Serine Endopeptidases | 2 | 2012 | 1032 | 0.120 |
Why?
|
| T-Lymphocytes, Cytotoxic | 5 | 2018 | 1797 | 0.120 |
Why?
|
| Bacteroidetes | 1 | 2015 | 85 | 0.120 |
Why?
|
| Receptors, Interleukin-7 | 2 | 2013 | 41 | 0.120 |
Why?
|
| Nucleic Acid Conformation | 2 | 2017 | 899 | 0.120 |
Why?
|
| Mutagenesis | 3 | 2017 | 1230 | 0.120 |
Why?
|
| Synovial Membrane | 2 | 2009 | 536 | 0.120 |
Why?
|
| Histones | 3 | 2010 | 2595 | 0.120 |
Why?
|
| Pancreatitis | 2 | 2016 | 1087 | 0.120 |
Why?
|
| Phosphorylation | 6 | 2015 | 8332 | 0.120 |
Why?
|
| Animals, Outbred Strains | 2 | 2010 | 20 | 0.120 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2014 | 35 | 0.120 |
Why?
|
| Models, Molecular | 6 | 2017 | 5443 | 0.110 |
Why?
|
| Genetics, Population | 3 | 2015 | 946 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2023 | 12242 | 0.110 |
Why?
|
| Integrins | 1 | 2018 | 845 | 0.110 |
Why?
|
| I-kappa B Proteins | 1 | 2014 | 210 | 0.110 |
Why?
|
| T-Box Domain Proteins | 1 | 2016 | 473 | 0.110 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2019 | 856 | 0.110 |
Why?
|
| Lymphopoiesis | 1 | 2014 | 133 | 0.110 |
Why?
|
| Aging | 7 | 2019 | 8761 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2015 | 458 | 0.110 |
Why?
|
| Germ-Free Life | 4 | 2017 | 187 | 0.110 |
Why?
|
| Denervation | 1 | 2014 | 265 | 0.110 |
Why?
|
| STAT Transcription Factors | 1 | 2014 | 190 | 0.110 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1797 | 0.110 |
Why?
|
| Trans-Activators | 3 | 2017 | 2858 | 0.110 |
Why?
|
| Zebrafish | 1 | 2024 | 3038 | 0.110 |
Why?
|
| Receptors, Complement | 2 | 2012 | 254 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2016 | 4362 | 0.110 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2017 | 697 | 0.100 |
Why?
|
| Epitopes | 14 | 1999 | 2526 | 0.100 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 15965 | 0.100 |
Why?
|
| Mucous Membrane | 1 | 2016 | 660 | 0.100 |
Why?
|
| Escherichia coli | 3 | 2022 | 4220 | 0.100 |
Why?
|
| Immunoglobulins | 5 | 2000 | 856 | 0.100 |
Why?
|
| Cell Line | 11 | 2014 | 15609 | 0.100 |
Why?
|
| Hyperplasia | 1 | 2016 | 1154 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2021 | 1397 | 0.100 |
Why?
|
| Computational Biology | 3 | 2014 | 3546 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 12 | 2013 | 9263 | 0.100 |
Why?
|
| Multigene Family | 2 | 2014 | 1081 | 0.100 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2014 | 272 | 0.100 |
Why?
|
| Operon | 4 | 1984 | 372 | 0.100 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2012 | 48 | 0.100 |
Why?
|
| Simian virus 40 | 3 | 1984 | 292 | 0.100 |
Why?
|
| Cell Division | 6 | 2004 | 4479 | 0.100 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2012 | 85 | 0.100 |
Why?
|
| Adaptive Immunity | 5 | 2017 | 736 | 0.100 |
Why?
|
| Period Circadian Proteins | 1 | 2012 | 97 | 0.100 |
Why?
|
| Hindlimb | 1 | 2014 | 516 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 4586 | 0.100 |
Why?
|
| Protein Conformation | 5 | 2017 | 3973 | 0.100 |
Why?
|
| Time Perception | 1 | 2012 | 86 | 0.100 |
Why?
|
| Receptor, Anaphylatoxin C5a | 2 | 2010 | 87 | 0.100 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2012 | 174 | 0.100 |
Why?
|
| Metals, Rare Earth | 1 | 2011 | 16 | 0.100 |
Why?
|
| Interleukin-1alpha | 2 | 2010 | 86 | 0.100 |
Why?
|
| Mice, Obese | 3 | 2024 | 418 | 0.100 |
Why?
|
| Nobel Prize | 1 | 2011 | 46 | 0.090 |
Why?
|
| Fluorescent Dyes | 2 | 2017 | 1924 | 0.090 |
Why?
|
| Antigens, Viral | 3 | 1997 | 992 | 0.090 |
Why?
|
| Transformation, Genetic | 2 | 1989 | 194 | 0.090 |
Why?
|
| GATA1 Transcription Factor | 1 | 2012 | 307 | 0.090 |
Why?
|
| Fluorescence | 1 | 2013 | 760 | 0.090 |
Why?
|
| Hematopoiesis | 1 | 2020 | 2058 | 0.090 |
Why?
|
| Genome-Wide Association Study | 5 | 2014 | 12774 | 0.090 |
Why?
|
| Kinetics | 7 | 2024 | 6348 | 0.090 |
Why?
|
| Ikaros Transcription Factor | 1 | 2012 | 233 | 0.090 |
Why?
|
| Transgenes | 5 | 2009 | 1015 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2004 | 588 | 0.090 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 3826 | 0.090 |
Why?
|
| Integrases | 2 | 2011 | 520 | 0.090 |
Why?
|
| Case-Control Studies | 4 | 2021 | 22293 | 0.090 |
Why?
|
| Fibrinogen | 1 | 2014 | 892 | 0.090 |
Why?
|
| RNA Splicing | 3 | 2015 | 906 | 0.090 |
Why?
|
| DNA, Complementary | 5 | 2004 | 1992 | 0.090 |
Why?
|
| Thinness | 2 | 2014 | 483 | 0.090 |
Why?
|
| Adoptive Transfer | 3 | 2021 | 825 | 0.090 |
Why?
|
| Biology | 1 | 2012 | 291 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 2 | 2021 | 1465 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2018 | 16029 | 0.090 |
Why?
|
| Nuclear Proteins | 6 | 2015 | 5808 | 0.090 |
Why?
|
| Antibody Specificity | 3 | 2009 | 1065 | 0.090 |
Why?
|
| Microvessels | 1 | 2014 | 586 | 0.090 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 873 | 0.080 |
Why?
|
| Transfection | 10 | 2000 | 5767 | 0.080 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2019 | 262 | 0.080 |
Why?
|
| Adjuvants, Immunologic | 1 | 2015 | 998 | 0.080 |
Why?
|
| Science | 1 | 2012 | 239 | 0.080 |
Why?
|
| Cell Nucleus | 4 | 2012 | 2889 | 0.080 |
Why?
|
| Integrin alpha Chains | 1 | 2010 | 95 | 0.080 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2015 | 558 | 0.080 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2011 | 240 | 0.080 |
Why?
|
| Lod Score | 1 | 2010 | 600 | 0.080 |
Why?
|
| Neoplasms | 1 | 2018 | 22386 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2011 | 797 | 0.080 |
Why?
|
| Natural Killer T-Cells | 1 | 2012 | 318 | 0.080 |
Why?
|
| Bacteriocins | 1 | 2009 | 88 | 0.080 |
Why?
|
| Antigens, Neoplasm | 4 | 2010 | 2003 | 0.080 |
Why?
|
| Drug Synergism | 1 | 2013 | 1765 | 0.080 |
Why?
|
| Skin | 1 | 2023 | 4520 | 0.080 |
Why?
|
| Genes, Reporter | 5 | 2014 | 1525 | 0.080 |
Why?
|
| Tetracycline | 3 | 2005 | 216 | 0.080 |
Why?
|
| Polyethyleneimine | 3 | 1998 | 68 | 0.080 |
Why?
|
| Lymphocytes | 5 | 2006 | 2611 | 0.080 |
Why?
|
| Ovum | 1 | 1989 | 187 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2014 | 3594 | 0.080 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2010 | 381 | 0.080 |
Why?
|
| Hematopoietic System | 1 | 2008 | 110 | 0.080 |
Why?
|
| NFATC Transcription Factors | 2 | 2011 | 394 | 0.080 |
Why?
|
| Lymphocyte Count | 6 | 2012 | 793 | 0.080 |
Why?
|
| Consensus Sequence | 2 | 2023 | 363 | 0.080 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2010 | 393 | 0.080 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 621 | 0.080 |
Why?
|
| Alternative Splicing | 1 | 2013 | 1094 | 0.080 |
Why?
|
| Chromosome Inversion | 1 | 2008 | 119 | 0.080 |
Why?
|
| Toll-Like Receptors | 1 | 2011 | 582 | 0.070 |
Why?
|
| Microscopy, Confocal | 3 | 2013 | 1977 | 0.070 |
Why?
|
| Androstenes | 1 | 2009 | 186 | 0.070 |
Why?
|
| Adipogenesis | 2 | 2024 | 370 | 0.070 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 399 | 0.070 |
Why?
|
| Glycolysis | 1 | 2012 | 838 | 0.070 |
Why?
|
| Ovalbumin | 5 | 1999 | 678 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 3 | 2011 | 2640 | 0.070 |
Why?
|
| Neutrophil Infiltration | 1 | 2010 | 396 | 0.070 |
Why?
|
| Colonic Neoplasms | 2 | 2018 | 2544 | 0.070 |
Why?
|
| Bone Marrow | 2 | 2017 | 2929 | 0.070 |
Why?
|
| Child | 6 | 2024 | 80863 | 0.070 |
Why?
|
| Prodrugs | 1 | 2009 | 274 | 0.070 |
Why?
|
| Th1 Cells | 3 | 2005 | 1044 | 0.070 |
Why?
|
| Genotype | 6 | 2018 | 13047 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2012 | 1196 | 0.070 |
Why?
|
| Epithelium | 2 | 2008 | 1610 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 20231 | 0.070 |
Why?
|
| Repressor Proteins | 4 | 2013 | 2987 | 0.070 |
Why?
|
| Terminology as Topic | 3 | 2013 | 1539 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 1969 | 0.070 |
Why?
|
| Stem Cells | 4 | 2016 | 3538 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 1152 | 0.070 |
Why?
|
| Gene Rearrangement | 2 | 2007 | 1139 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2010 | 1197 | 0.070 |
Why?
|
| Genome, Human | 2 | 2017 | 4453 | 0.070 |
Why?
|
| Cell Death | 3 | 2003 | 1684 | 0.070 |
Why?
|
| Interleukin-12 | 2 | 2007 | 578 | 0.070 |
Why?
|
| Immunity, Active | 1 | 2006 | 58 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2012 | 950 | 0.070 |
Why?
|
| Freund's Adjuvant | 1 | 2006 | 144 | 0.070 |
Why?
|
| Lung | 3 | 2022 | 10090 | 0.070 |
Why?
|
| Chemokines | 1 | 2010 | 963 | 0.060 |
Why?
|
| Leukocytes | 1 | 2014 | 2030 | 0.060 |
Why?
|
| Interleukin-1beta | 2 | 2010 | 1021 | 0.060 |
Why?
|
| Data Display | 1 | 2006 | 174 | 0.060 |
Why?
|
| beta 2-Microglobulin | 5 | 1999 | 329 | 0.060 |
Why?
|
| Spermatozoa | 1 | 1989 | 631 | 0.060 |
Why?
|
| Protein Multimerization | 3 | 2023 | 980 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2014 | 2491 | 0.060 |
Why?
|
| Endocarditis | 1 | 2009 | 355 | 0.060 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 903 | 0.060 |
Why?
|
| DNA, Recombinant | 6 | 1989 | 455 | 0.060 |
Why?
|
| Lymphocyte Depletion | 2 | 2009 | 605 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 1 | 2014 | 1095 | 0.060 |
Why?
|
| Dimerization | 2 | 2022 | 888 | 0.060 |
Why?
|
| Genes | 6 | 1983 | 1824 | 0.060 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2004 | 40 | 0.060 |
Why?
|
| Biological Evolution | 3 | 2024 | 1081 | 0.060 |
Why?
|
| Diabetes Mellitus | 4 | 2011 | 5887 | 0.060 |
Why?
|
| Haplotypes | 8 | 2010 | 2725 | 0.060 |
Why?
|
| Oncostatin M | 1 | 2024 | 42 | 0.060 |
Why?
|
| Luciferases | 4 | 2006 | 712 | 0.060 |
Why?
|
| Neurogenesis | 1 | 2010 | 866 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 3790 | 0.060 |
Why?
|
| Histamine | 1 | 2006 | 500 | 0.060 |
Why?
|
| Cell Transplantation | 1 | 2006 | 475 | 0.060 |
Why?
|
| Research | 1 | 2012 | 1984 | 0.060 |
Why?
|
| Hybridomas | 9 | 1998 | 444 | 0.060 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2024 | 614 | 0.060 |
Why?
|
| Interleukins | 1 | 2008 | 792 | 0.060 |
Why?
|
| Lentivirus | 1 | 2006 | 519 | 0.050 |
Why?
|
| Gastritis | 1 | 2005 | 200 | 0.050 |
Why?
|
| Genetic Markers | 2 | 2010 | 2604 | 0.050 |
Why?
|
| Jurkat Cells | 2 | 2020 | 743 | 0.050 |
Why?
|
| Adult | 10 | 2022 | 223542 | 0.050 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2004 | 200 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2015 | 1930 | 0.050 |
Why?
|
| Antigens, CD1 | 2 | 1995 | 434 | 0.050 |
Why?
|
| Tarsus, Animal | 1 | 2002 | 5 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2006 | 545 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2006 | 3408 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2024 | 522 | 0.050 |
Why?
|
| CpG Islands | 1 | 2007 | 1209 | 0.050 |
Why?
|
| Immunohistochemistry | 4 | 2015 | 11138 | 0.050 |
Why?
|
| Mitochondria, Muscle | 1 | 2023 | 172 | 0.050 |
Why?
|
| Apoptosis | 3 | 2019 | 9526 | 0.050 |
Why?
|
| Receptors, Glucagon | 2 | 2013 | 90 | 0.050 |
Why?
|
| Young Adult | 6 | 2021 | 60045 | 0.050 |
Why?
|
| Motor Activity | 1 | 2012 | 2722 | 0.050 |
Why?
|
| Adolescent | 8 | 2021 | 89168 | 0.050 |
Why?
|
| Prediabetic State | 1 | 2008 | 548 | 0.050 |
Why?
|
| Membrane Proteins | 3 | 2012 | 7895 | 0.050 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2001 | 29 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2022 | 190 | 0.050 |
Why?
|
| Genes, Regulator | 4 | 1994 | 373 | 0.050 |
Why?
|
| ARNTL Transcription Factors | 1 | 2022 | 97 | 0.050 |
Why?
|
| Disease | 1 | 2007 | 673 | 0.050 |
Why?
|
| Immunotherapy | 2 | 2008 | 4728 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2021 | 41797 | 0.050 |
Why?
|
| Adenoviridae | 4 | 2000 | 1098 | 0.050 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 3 | 1999 | 32 | 0.050 |
Why?
|
| Plasmids | 9 | 2000 | 2269 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 1738 | 0.050 |
Why?
|
| Immunoconjugates | 2 | 2000 | 968 | 0.050 |
Why?
|
| Osteoarthritis | 1 | 2009 | 1070 | 0.050 |
Why?
|
| Immunoglobulin Variable Region | 3 | 1993 | 420 | 0.050 |
Why?
|
| Homeodomain Proteins | 3 | 2018 | 2430 | 0.050 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 4 | 1993 | 111 | 0.050 |
Why?
|
| Nippostrongylus | 1 | 2021 | 21 | 0.050 |
Why?
|
| Lipolysis | 1 | 2022 | 211 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2002 | 257 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 10 | 2016 | 6091 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2006 | 1364 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2010 | 2450 | 0.050 |
Why?
|
| Membrane Glycoproteins | 3 | 1997 | 3713 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 380 | 0.050 |
Why?
|
| Nematospiroides dubius | 1 | 2021 | 37 | 0.050 |
Why?
|
| Serotonin | 1 | 2006 | 1047 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 6400 | 0.050 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2006 | 748 | 0.050 |
Why?
|
| Salmonella enterica | 1 | 2021 | 76 | 0.050 |
Why?
|
| Citrobacter rodentium | 1 | 2021 | 64 | 0.040 |
Why?
|
| Superantigens | 2 | 1997 | 126 | 0.040 |
Why?
|
| H-Y Antigen | 2 | 1997 | 42 | 0.040 |
Why?
|
| Heart | 3 | 2008 | 4451 | 0.040 |
Why?
|
| Nanostructures | 1 | 2005 | 553 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2002 | 348 | 0.040 |
Why?
|
| DNA Restriction Enzymes | 5 | 1983 | 548 | 0.040 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2020 | 31 | 0.040 |
Why?
|
| Cell Movement | 3 | 2014 | 5223 | 0.040 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1983 | 648 | 0.040 |
Why?
|
| Amino Acid Substitution | 2 | 2006 | 1744 | 0.040 |
Why?
|
| CD4-CD8 Ratio | 3 | 2010 | 114 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2009 | 4572 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2002 | 621 | 0.040 |
Why?
|
| Germinal Center | 1 | 2022 | 379 | 0.040 |
Why?
|
| HLA-D Antigens | 2 | 1991 | 130 | 0.040 |
Why?
|
| Time Factors | 8 | 2012 | 40271 | 0.040 |
Why?
|
| Hypoglycemic Agents | 2 | 2012 | 3111 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2023 | 652 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2021 | 42623 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 4534 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 2021 | 321 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2011 | 3665 | 0.040 |
Why?
|
| Genes, Homeobox | 3 | 1989 | 289 | 0.040 |
Why?
|
| Lipopolysaccharides | 3 | 2014 | 2216 | 0.040 |
Why?
|
| Cloning, Molecular | 9 | 1997 | 4175 | 0.040 |
Why?
|
| Peptide Library | 1 | 2020 | 353 | 0.040 |
Why?
|
| Wound Healing | 2 | 2023 | 2819 | 0.040 |
Why?
|
| Infant | 1 | 2021 | 36497 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2008 | 2067 | 0.040 |
Why?
|
| Joint Diseases | 1 | 2002 | 460 | 0.040 |
Why?
|
| K562 Cells | 1 | 2020 | 645 | 0.040 |
Why?
|
| Integrin alpha4 | 1 | 2018 | 88 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2004 | 1185 | 0.040 |
Why?
|
| Integrin alpha4beta1 | 1 | 2018 | 119 | 0.040 |
Why?
|
| Enterovirus B, Human | 1 | 1998 | 49 | 0.040 |
Why?
|
| DNA Probes | 2 | 2012 | 542 | 0.040 |
Why?
|
| Cardiotoxins | 1 | 2018 | 36 | 0.040 |
Why?
|
| Liver | 3 | 2019 | 7575 | 0.040 |
Why?
|
| Genes, Dominant | 3 | 2000 | 856 | 0.040 |
Why?
|
| Hippocampus | 1 | 2010 | 3783 | 0.040 |
Why?
|
| Ankle Joint | 1 | 2002 | 447 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2002 | 1503 | 0.040 |
Why?
|
| Molecular Mimicry | 1 | 1998 | 214 | 0.040 |
Why?
|
| Antigens, Surface | 1 | 2001 | 1615 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 4425 | 0.040 |
Why?
|
| Muscles | 1 | 2022 | 1582 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2012 | 221 | 0.040 |
Why?
|
| Receptors, Interleukin | 1 | 2018 | 242 | 0.030 |
Why?
|
| Software | 1 | 2011 | 4463 | 0.030 |
Why?
|
| Viral Core Proteins | 2 | 1996 | 158 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2021 | 2944 | 0.030 |
Why?
|
| Peptide Fragments | 5 | 1999 | 5152 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 6 | 1994 | 288 | 0.030 |
Why?
|
| Immunoglobulin D | 1 | 1996 | 55 | 0.030 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 1997 | 140 | 0.030 |
Why?
|
| Cell Survival | 4 | 2001 | 5801 | 0.030 |
Why?
|
| Clone Cells | 6 | 2002 | 1672 | 0.030 |
Why?
|
| Rats | 2 | 2012 | 23839 | 0.030 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2017 | 120 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2015 | 36840 | 0.030 |
Why?
|
| Craniosynostoses | 1 | 2000 | 416 | 0.030 |
Why?
|
| Egg Proteins | 2 | 1999 | 58 | 0.030 |
Why?
|
| Mice, Inbred DBA | 4 | 1999 | 624 | 0.030 |
Why?
|
| beta-Galactosidase | 4 | 1998 | 575 | 0.030 |
Why?
|
| Algorithms | 2 | 2013 | 14158 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2016 | 111 | 0.030 |
Why?
|
| Guanidines | 1 | 1996 | 194 | 0.030 |
Why?
|
| Stochastic Processes | 3 | 2008 | 359 | 0.030 |
Why?
|
| Animals, Newborn | 4 | 1995 | 2696 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2017 | 462 | 0.030 |
Why?
|
| Genes, RAG-1 | 1 | 1995 | 68 | 0.030 |
Why?
|
| Recombination, Genetic | 4 | 2000 | 1526 | 0.030 |
Why?
|
| Cartilage, Articular | 1 | 2002 | 1104 | 0.030 |
Why?
|
| Recombinant Proteins | 5 | 2006 | 6527 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 3 | 2017 | 7471 | 0.030 |
Why?
|
| Muramidase | 2 | 1998 | 165 | 0.030 |
Why?
|
| Th1-Th2 Balance | 1 | 2014 | 38 | 0.030 |
Why?
|
| Gene Targeting | 2 | 2011 | 842 | 0.030 |
Why?
|
| Spermine | 1 | 1994 | 70 | 0.030 |
Why?
|
| Photochemical Processes | 1 | 2014 | 86 | 0.030 |
Why?
|
| Rheumatic Fever | 1 | 2014 | 73 | 0.030 |
Why?
|
| Antibody Formation | 5 | 1993 | 1393 | 0.030 |
Why?
|
| Sequence Alignment | 3 | 2011 | 2184 | 0.030 |
Why?
|
| Boron Compounds | 1 | 2015 | 196 | 0.030 |
Why?
|
| Linkage Disequilibrium | 2 | 2010 | 1998 | 0.030 |
Why?
|
| Brain Diseases | 1 | 2002 | 1553 | 0.030 |
Why?
|
| Somatostatin | 1 | 2015 | 448 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 1232 | 0.030 |
Why?
|
| Chromosome Deletion | 5 | 1999 | 1390 | 0.030 |
Why?
|
| Glucagon | 1 | 2015 | 534 | 0.030 |
Why?
|
| Middle Aged | 5 | 2021 | 223418 | 0.030 |
Why?
|
| Nucleoproteins | 1 | 1993 | 110 | 0.030 |
Why?
|
| Serum | 1 | 2014 | 208 | 0.030 |
Why?
|
| Epigenomics | 1 | 2019 | 956 | 0.030 |
Why?
|
| Microcirculation | 2 | 2010 | 1282 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2000 | 3735 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2001 | 1892 | 0.030 |
Why?
|
| Paralysis | 1 | 2014 | 250 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3816 | 0.030 |
Why?
|
| Probiotics | 1 | 2016 | 382 | 0.030 |
Why?
|
| Genes, Immunoglobulin | 1 | 1993 | 286 | 0.030 |
Why?
|
| Cell Communication | 1 | 2020 | 1662 | 0.030 |
Why?
|
| Acetylation | 1 | 2015 | 1053 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2017 | 613 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2013 | 268 | 0.030 |
Why?
|
| Neutralization Tests | 2 | 2009 | 740 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1996 | 1355 | 0.020 |
Why?
|
| Carboxypeptidases A | 1 | 2011 | 28 | 0.020 |
Why?
|
| Receptors, Neurotensin | 1 | 2012 | 16 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 2016 | 708 | 0.020 |
Why?
|
| Graft Rejection | 3 | 1994 | 4505 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 1994 | 706 | 0.020 |
Why?
|
| Mice, SCID | 3 | 2010 | 2633 | 0.020 |
Why?
|
| Models, Biological | 3 | 2015 | 9505 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10784 | 0.020 |
Why?
|
| Diet | 2 | 2024 | 8098 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1996 | 1688 | 0.020 |
Why?
|
| RNA | 3 | 2018 | 2727 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2008 | 4713 | 0.020 |
Why?
|
| Fetus | 3 | 2007 | 1883 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 616 | 0.020 |
Why?
|
| Exons | 3 | 1992 | 2392 | 0.020 |
Why?
|
| Stem Cell Factor | 1 | 2011 | 195 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2014 | 839 | 0.020 |
Why?
|
| Muscular Dystrophies | 1 | 2013 | 394 | 0.020 |
Why?
|
| Streptozocin | 1 | 2011 | 195 | 0.020 |
Why?
|
| Hemagglutinins, Viral | 1 | 1990 | 66 | 0.020 |
Why?
|
| International Cooperation | 1 | 2017 | 1439 | 0.020 |
Why?
|
| Ankle | 1 | 2014 | 354 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 6320 | 0.020 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 2 | 2006 | 111 | 0.020 |
Why?
|
| Salmonella Infections | 1 | 2012 | 172 | 0.020 |
Why?
|
| Oxidoreductases, O-Demethylating | 1 | 2010 | 4 | 0.020 |
Why?
|
| Inbreeding | 1 | 2010 | 48 | 0.020 |
Why?
|
| Nucleotides | 1 | 1993 | 455 | 0.020 |
Why?
|
| Animals, Laboratory | 1 | 2010 | 46 | 0.020 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2016 | 542 | 0.020 |
Why?
|
| Transplantation Immunology | 1 | 1993 | 538 | 0.020 |
Why?
|
| Orthomyxoviridae Infections | 1 | 1993 | 255 | 0.020 |
Why?
|
| Genetic Drift | 1 | 2010 | 41 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1991 | 370 | 0.020 |
Why?
|
| Glycine | 1 | 1994 | 672 | 0.020 |
Why?
|
| Epididymis | 1 | 2012 | 227 | 0.020 |
Why?
|
| Antigens, Viral, Tumor | 2 | 1981 | 153 | 0.020 |
Why?
|
| Aged | 2 | 2021 | 171520 | 0.020 |
Why?
|
| Radiation Chimera | 2 | 2002 | 216 | 0.020 |
Why?
|
| Sex Factors | 1 | 2024 | 10647 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1991 | 431 | 0.020 |
Why?
|
| Hybridization, Genetic | 2 | 2001 | 102 | 0.020 |
Why?
|
| Ferric Compounds | 1 | 2012 | 379 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 3463 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2011 | 429 | 0.020 |
Why?
|
| Mice, Nude | 2 | 2007 | 3635 | 0.020 |
Why?
|
| Albumins | 1 | 1992 | 578 | 0.020 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1989 | 52 | 0.020 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2010 | 112 | 0.020 |
Why?
|
| Fasting | 1 | 2016 | 1608 | 0.020 |
Why?
|
| Amino Acids | 1 | 1996 | 1714 | 0.020 |
Why?
|
| Listeriosis | 1 | 2010 | 147 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2013 | 1889 | 0.020 |
Why?
|
| Introns | 1 | 1992 | 970 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 2010 | 458 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2000 | 3612 | 0.020 |
Why?
|
| Genes, MHC Class I | 1 | 1990 | 236 | 0.020 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2010 | 121 | 0.020 |
Why?
|
| Antigens, CD20 | 1 | 2010 | 199 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2012 | 462 | 0.020 |
Why?
|
| Cytochrome c Group | 2 | 2000 | 123 | 0.020 |
Why?
|
| Eosinophils | 1 | 2014 | 955 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 423 | 0.020 |
Why?
|
| Chickens | 5 | 1989 | 860 | 0.020 |
Why?
|
| Oligonucleotide Probes | 2 | 2004 | 417 | 0.020 |
Why?
|
| Magnetite Nanoparticles | 1 | 2010 | 318 | 0.020 |
Why?
|
| Structure-Activity Relationship | 5 | 1994 | 3073 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 2 | 2010 | 2702 | 0.020 |
Why?
|
| Dextrans | 1 | 2010 | 574 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 17149 | 0.020 |
Why?
|
| Leukotrienes | 1 | 2010 | 230 | 0.020 |
Why?
|
| Listeria monocytogenes | 1 | 2010 | 246 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 631 | 0.020 |
Why?
|
| Actigraphy | 1 | 2012 | 526 | 0.020 |
Why?
|
| Oligonucleotides | 2 | 2007 | 564 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2015 | 1855 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2008 | 64 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2008 | 189 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2016 | 2003 | 0.020 |
Why?
|
| HLA-DQ Antigens | 1 | 2008 | 190 | 0.020 |
Why?
|
| Cations | 2 | 1998 | 240 | 0.020 |
Why?
|
| Androstadienes | 1 | 2009 | 348 | 0.020 |
Why?
|
| Metal Nanoparticles | 1 | 2012 | 406 | 0.020 |
Why?
|
| Mucin-6 | 1 | 2007 | 15 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2009 | 574 | 0.020 |
Why?
|
| Methylation | 1 | 2010 | 1077 | 0.020 |
Why?
|
| DNA Repair | 1 | 2017 | 2051 | 0.020 |
Why?
|
| DNA Primers | 2 | 2002 | 2826 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 876 | 0.020 |
Why?
|
| Antibody Affinity | 2 | 2002 | 252 | 0.020 |
Why?
|
| Age Factors | 3 | 2018 | 18478 | 0.020 |
Why?
|
| Blood | 1 | 2009 | 597 | 0.020 |
Why?
|
| Globins | 3 | 2000 | 405 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 1706 | 0.020 |
Why?
|
| Lymphopenia | 1 | 2009 | 290 | 0.020 |
Why?
|
| DNA Damage | 1 | 2017 | 2461 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 695 | 0.020 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 1999 | 94 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2000 | 4948 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1604 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1660 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6242 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 3861 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 2399 | 0.020 |
Why?
|
| Cell Compartmentation | 2 | 1997 | 383 | 0.020 |
Why?
|
| Cross Reactions | 2 | 1999 | 828 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2011 | 1474 | 0.020 |
Why?
|
| Biological Transport | 3 | 1996 | 2089 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2010 | 1775 | 0.020 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 828 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2013 | 2206 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 3437 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2010 | 968 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2006 | 313 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 2072 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2014 | 875 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 3939 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2005 | 194 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2011 | 1510 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1992 | 1056 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 940 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2008 | 727 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2014 | 2630 | 0.010 |
Why?
|
| Anaphylaxis | 1 | 2011 | 758 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1996 | 3212 | 0.010 |
Why?
|
| Skin Transplantation | 3 | 1994 | 1097 | 0.010 |
Why?
|
| Placebos | 1 | 2008 | 1668 | 0.010 |
Why?
|
| Macromolecular Substances | 3 | 1991 | 1435 | 0.010 |
Why?
|
| Mucins | 1 | 2007 | 570 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 3 | 2000 | 6135 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2011 | 2772 | 0.010 |
Why?
|
| Pedigree | 1 | 2011 | 4545 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 2742 | 0.010 |
Why?
|
| Rabbits | 3 | 2000 | 4786 | 0.010 |
Why?
|
| Phylogeny | 1 | 2010 | 2846 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2009 | 3103 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2008 | 2596 | 0.010 |
Why?
|
| Magnetics | 1 | 2005 | 599 | 0.010 |
Why?
|
| Chick Embryo | 2 | 1994 | 978 | 0.010 |
Why?
|
| Mitosis | 1 | 2007 | 1191 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 2751 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2016 | 2444 | 0.010 |
Why?
|
| Brain | 4 | 1996 | 27438 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 2002 | 277 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2006 | 1987 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8730 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 2 | 1995 | 662 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2008 | 3615 | 0.010 |
Why?
|
| Chimera | 2 | 1994 | 454 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 8201 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 2964 | 0.010 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1981 | 133 | 0.010 |
Why?
|
| Hybrid Cells | 2 | 1991 | 421 | 0.010 |
Why?
|
| Blotting, Southern | 2 | 1991 | 777 | 0.010 |
Why?
|
| Antirheumatic Agents | 1 | 2010 | 1374 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2014 | 2891 | 0.010 |
Why?
|
| Viral Envelope Proteins | 2 | 1996 | 641 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 2007 | 975 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1990 | 2680 | 0.010 |
Why?
|
| Age of Onset | 1 | 2007 | 3342 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2005 | 2342 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2011 | 2056 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 4780 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2000 | 463 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2014 | 3245 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2000 | 654 | 0.010 |
Why?
|
| Models, Genetic | 3 | 1997 | 3442 | 0.010 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 1999 | 85 | 0.010 |
Why?
|
| Calcium | 1 | 2012 | 5793 | 0.010 |
Why?
|
| Blotting, Northern | 2 | 1990 | 1553 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6537 | 0.010 |
Why?
|
| Binding, Competitive | 2 | 1990 | 1144 | 0.010 |
Why?
|
| Restriction Mapping | 2 | 1989 | 851 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 13708 | 0.010 |
Why?
|
| COS Cells | 1 | 2000 | 1136 | 0.010 |
Why?
|
| Pregnancy | 2 | 2017 | 30179 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2012 | 5103 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 1998 | 267 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 1816 | 0.010 |
Why?
|
| Receptors, Interferon | 1 | 1997 | 115 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2004 | 1322 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2017 | 26395 | 0.010 |
Why?
|
| Genes, Viral | 1 | 1998 | 654 | 0.010 |
Why?
|
| Immunoglobulin Class Switching | 1 | 1998 | 289 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1997 | 557 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1998 | 1379 | 0.010 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 1995 | 93 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2002 | 1308 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1996 | 510 | 0.010 |
Why?
|
| Overweight | 1 | 2007 | 2428 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2005 | 1905 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1999 | 2565 | 0.010 |
Why?
|
| Blood Glucose | 2 | 2006 | 6429 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 1497 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1987 | 1734 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12096 | 0.010 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 1995 | 175 | 0.010 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1994 | 76 | 0.010 |
Why?
|
| Methotrexate | 1 | 1981 | 1722 | 0.010 |
Why?
|
| Protein Biosynthesis | 2 | 1992 | 2096 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1981 | 2206 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 8559 | 0.010 |
Why?
|
| Immunoglobulin Joining Region | 1 | 1993 | 37 | 0.010 |
Why?
|
| TATA-Box Binding Protein | 1 | 1993 | 99 | 0.010 |
Why?
|
| TATA Box | 1 | 1993 | 127 | 0.010 |
Why?
|
| Submandibular Gland | 1 | 1993 | 85 | 0.010 |
Why?
|
| Templates, Genetic | 1 | 1993 | 189 | 0.010 |
Why?
|
| Ionomycin | 1 | 1993 | 110 | 0.010 |
Why?
|
| Myocardium | 2 | 1998 | 4788 | 0.010 |
Why?
|
| Nucleocapsid Proteins | 1 | 1993 | 78 | 0.010 |
Why?
|
| Microinjections | 1 | 1994 | 322 | 0.010 |
Why?
|
| Capsid | 1 | 1996 | 437 | 0.010 |
Why?
|
| Transcription Factor TFIID | 1 | 1993 | 150 | 0.010 |
Why?
|
| Alanine | 1 | 1996 | 613 | 0.010 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 1992 | 41 | 0.010 |
Why?
|
| Endosomes | 1 | 1996 | 526 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1993 | 310 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1996 | 1223 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1996 | 568 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2014 | 8721 | 0.010 |
Why?
|
| DNA Mutational Analysis | 2 | 1991 | 4120 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1992 | 221 | 0.010 |
Why?
|
| Arginine | 1 | 1996 | 923 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 826 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1999 | 2674 | 0.010 |
Why?
|
| Heterozygote | 1 | 1998 | 2792 | 0.010 |
Why?
|
| RNA, Viral | 1 | 1980 | 2865 | 0.010 |
Why?
|
| Zea mays | 1 | 1992 | 110 | 0.010 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1991 | 141 | 0.010 |
Why?
|
| Enterotoxins | 1 | 1992 | 366 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1995 | 1906 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1990 | 260 | 0.010 |
Why?
|
| Poly A | 1 | 1990 | 180 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1991 | 266 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 1995 | 877 | 0.010 |
Why?
|
| Trypsin | 1 | 1990 | 494 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 1996 | 1129 | 0.010 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1990 | 161 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 1990 | 425 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 1992 | 812 | 0.010 |
Why?
|
| Fungi | 1 | 1992 | 346 | 0.010 |
Why?
|
| Horses | 1 | 1989 | 296 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1993 | 2477 | 0.000 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1988 | 342 | 0.000 |
Why?
|
| Proteins | 2 | 1993 | 6008 | 0.000 |
Why?
|
| Gene Library | 1 | 1990 | 1064 | 0.000 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1987 | 298 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 59680 | 0.000 |
Why?
|
| Glutamates | 1 | 1988 | 385 | 0.000 |
Why?
|
| Lipids | 1 | 1998 | 3346 | 0.000 |
Why?
|
| Immunoenzyme Techniques | 1 | 1990 | 1706 | 0.000 |
Why?
|
| Embryo, Mammalian | 1 | 1993 | 1674 | 0.000 |
Why?
|
| Sheep | 1 | 1989 | 1451 | 0.000 |
Why?
|
| Homozygote | 1 | 1991 | 1779 | 0.000 |
Why?
|
| Chelating Agents | 1 | 1987 | 385 | 0.000 |
Why?
|
| Cross-Linking Reagents | 1 | 1989 | 692 | 0.000 |
Why?
|
| Stem Cell Transplantation | 1 | 1993 | 1602 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1994 | 4180 | 0.000 |
Why?
|
| Cattle | 1 | 1989 | 3830 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1993 | 3664 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2012 | 81834 | 0.000 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1993 | 1505 | 0.000 |
Why?
|
| Kidney | 1 | 1998 | 7064 | 0.000 |
Why?
|
| Deoxyribonucleases | 1 | 1984 | 209 | 0.000 |
Why?
|
| Glutamic Acid | 1 | 1988 | 1192 | 0.000 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1984 | 781 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2008 | 65409 | 0.000 |
Why?
|
| Risk Factors | 1 | 2008 | 74915 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1983 | 2173 | 0.000 |
Why?
|
| Nucleosomes | 1 | 1984 | 489 | 0.000 |
Why?
|
| Incidence | 1 | 1998 | 21552 | 0.000 |
Why?
|
| Swine | 1 | 1989 | 5996 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1979 | 1305 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1995 | 9066 | 0.000 |
Why?
|
| DNA Replication | 1 | 1984 | 1428 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1981 | 1599 | 0.000 |
Why?
|
| Protein Precursors | 1 | 1979 | 1133 | 0.000 |
Why?
|